|
Volumn 19, Issue 14, 2011, Pages 4366-4376
|
Synthesis and biological evaluation of novel 5-alkyl-2-arylthio-6-((3,4- dihydroquinolin-1(2H)-yl)methyl)pyrimidin-4(3H)-ones as potent non-nucleoside HIV-1 reverse transcriptase inhibitors
|
Author keywords
AIDS; Anti HIV 1 activity; HIV 1; NNRTIs; S DABOs
|
Indexed keywords
2 [4 CHLOROBENZYLTHIO] 6 [(3,4 DIHYDROQUINOLIN 1(2H) YL)METHYL]PYRIMIDIN 4(3H) ONE;
2 [4 CHLOROPHENYLCARBONYLMETHYLTHIO] 6 [(3,4 DIHYDROQUINOLIN 1(2H) YL)METHYL]PYRIMIDIN 4(3H) ONE;
2 [4 CYANOBENZYLTHIO] 6 [(3,4 DIHYDROQUINOLIN 1(2H) YL)METHYL]PYRIMIDIN 4(3H) ONE;
2 [4 CYANOPHENYLCARBONYLMETHYLTHIO] 6 [(3,4 DIHYDROQUINOLIN 1(2H) YL)METHYL]PYRIMIDIN 4(3H) ONE;
2 [4 FLUOROBENZYLTHIO] 6 [(3,4 DIHYDROQUINOLIN 1(2H) YL)METHYL]PYRIMIDIN 4(3H) ONE;
2 [4 FLUOROPHENYLCARBONYLMETHYLTHIO] 6 [(3,4 DIHYDROQUINOLIN 1(2H) YL)METHYL]PYRIMIDIN 4(3H) ONE;
2 [4 METHOXYBENZYLTHIO] 6 [(3,4 DIHYDROQUINOLIN 1(2H) YL)METHYL]PYRIMIDIN 4(3H) ONE;
2 [4 METHOXYLPHENYLCARBONYLMETHYLTHIO] 6 [(3,4 DIHYDROQUINOLIN 1(2H) YL)METHYL]PYRIMIDIN 4(3H) ONE;
2 [4 METHYLBENZYLTHIO] 6 [(3,4 DIHYDROQUINOLIN 1(2H) YL)METHYL]PYRIMIDIN 4(3H) ONE;
2 [4 METHYLPHENYLCARBONYLMETHYLTHIO] 6 [(3,4 DIHYDROQUINOLIN 1(2H) YL)METHYL]PYRIMIDIN 4(3H) ONE;
2 [4 NITROBENZYLTHIO] 6 [(3,4 DIHYDROQUINOLIN 1(2H) YL)METHYL]PYRIMIDIN 4(3H) ONE;
2 [4 NITROPHENYLCARBONYLMETHYLTHIO] 6 [(3,4 DIHYDROQUINOLIN 1(2H) YL)METHYL]PYRIMIDIN 4(3H) ONE;
2 BENZYLTHIO 6 [(3,4 DIHYDROQUINOLIN 1(2H) YL)METHYL]PYRIMIDIN 4(3H) ONE;
2 PHENYLCARBONYLMETHYLTHIO 6 [(3,4 DIHYDROQUINOLIN 1(2H) YL)METHYL]PYRIMIDIN 4(3H) ONE;
5 ALKYL 2 ARYLTHIO 6 [(3,4 DIHYDROQUINOLIN 1 (2H) YL)METHYL]PYRIMIDIN 4(3H) ONE DERIVATIVE;
5 ETHYL 2 [4 FLUOROPHENYLCARBONYLMETHYLTHIO] 6 [(3,4 DIHYDROQUINOLIN 1(2H) YL)METHYL]PYRIMIDIN 4(3H) ONE;
5 ETHYL 2 [4 METHOXYPHENYLCARBONYLMETHYLTHIO] 6 [(3,4 DIHYDROQUINOLIN 1(2H) YL)METHYL]PYRIMIDIN 4(3H) ONE;
5 ETHYL 2 PHENYLCARBONYLMETHYLTHIO 6 [(3,4 DIHYDROQUINOLIN 1(2H) YL)METHYL]PYRIMIDIN 4(3H) ONE;
5 METHYL 2 [4 CHLOROPHENYLCARBONYLMETHYLTHIO] 6 [(3,4 DIHYDROQUINOLIN 1(2H) YL)METHYL]PYRIMIDIN 4(3H) ONE;
5 METHYL 2 [4 CYANOPHENYLCARBONYLMETHYLTHIO] 6 [(3,4 DIHYDROQUINOLIN 1(2H) YL)METHYL]PYRIMIDIN 4(3H) ONE;
5 METHYL 2 [4 METHOXYPHENYLCARBONYLMETHYLTHIO] 6 [(3,4 DIHYDROQUINOLIN 1(2H) YL)METHYL]PYRIMIDIN 4(3H) ONE;
5 METHYL 2 [4 METHYLPHENYLCARBONYLMETHYLTHIO] 6 [(3,4 DIHYDROQUINOLIN 1(2H) YL)METHYL]PYRIMIDIN 4(3H) ONE;
5 METHYL 2 [4 NITROPHENYLCARBONYLMETHYLTHIO] 6 [(3,4 DIHYDROQUINOLIN 1(2H) YL)METHYL]PYRIMIDIN 4(3H) ONE;
5 METHYL 2 PHENYLCARBONYLMETHYLTHIO 6 [(3,4 DIHYDROQUINOLIN 1(2H) YL)METHYL]PYRIMIDIN 4(3H) ONE;
DELAVIRDINE;
EFAVIRENZ;
NEVIRAPINE;
NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
ZIDOVUDINE;
ANTIVIRAL ACTIVITY;
ARTICLE;
CANCER CELL CULTURE;
CONTROLLED STUDY;
DRUG POTENCY;
DRUG STRUCTURE;
DRUG SYNTHESIS;
ENZYME INHIBITION;
HUMAN IMMUNODEFICIENCY VIRUS 1;
IN VITRO STUDY;
STRUCTURE ACTIVITY RELATION;
VIRUS REPLICATION;
ANTI-HIV AGENTS;
CELL LINE, TUMOR;
CRYSTALLOGRAPHY, X-RAY;
DOSE-RESPONSE RELATIONSHIP, DRUG;
HIV REVERSE TRANSCRIPTASE;
HIV-1;
HIV-2;
HUMANS;
MICROBIAL SENSITIVITY TESTS;
MODELS, MOLECULAR;
MOLECULAR STRUCTURE;
PYRIMIDINONES;
REVERSE TRANSCRIPTASE INHIBITORS;
STEREOISOMERISM;
STRUCTURE-ACTIVITY RELATIONSHIP;
VIRUS REPLICATION;
HUMAN IMMUNODEFICIENCY VIRUS 1;
HUMAN IMMUNODEFICIENCY VIRUS 2;
|
EID: 79959946469
PISSN: 09680896
EISSN: 14643391
Source Type: Journal
DOI: 10.1016/j.bmc.2011.05.024 Document Type: Article |
Times cited : (31)
|
References (22)
|